Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

36 trials with published results (40%)

Research Maturity

76 completed trials (84% of total)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

4.4%

4 terminated out of 91 trials

Success Rate

95.0%

+8.5% vs benchmark

Late-Stage Pipeline

26%

24 trials in Phase 3/4

Results Transparency

47%

36 of 76 completed with results

Key Signals

36 with results95% success

Data Visualizations

Phase Distribution

80Total
Not Applicable (26)
Early P 1 (1)
P 1 (9)
P 2 (20)
P 3 (13)
P 4 (11)

Trial Status

Completed76
Unknown5
Withdrawn4
Terminated4
Recruiting2

Trial Success Rate

95.0%

Benchmark: 86.5%

Based on 76 completed trials

Clinical Trials (91)

Showing 20 of 20 trials
NCT07294118Phase 2Recruiting

Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage

NCT03718065Phase 2Completed

Impact of Lofexidine on Stress, Craving and Opioid Use

NCT03804619Not ApplicableWithdrawnPrimary

Accelerated Intermittent Theta-Burst Stimulation for Opiate Use Disorder

NCT03527485Not ApplicableCompletedPrimary

Imaging Synaptic Density in Cocaine and Opiate Addiction In Vivo Using 11UCB-J PET

NCT05995873Not ApplicableUnknown

A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.

NCT00439049Recruiting

Substance Abuse Pre-Treatment Screening Study

NCT03769025Phase 1Completed

Remote Observed Dosing of Suboxone to Improve Clinical Practice

NCT04156802Not ApplicableCompleted

Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain

NCT00842036Phase 2Completed

CRAFT Behavior Therapy: Treatment Entry Component

NCT00723697Completed

Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED)

NCT00684073Phase 4Completed

Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED)

NCT03681769Early Phase 1Completed

Developing Brain Stimulation as a Treatment for Chronic Pain in Opiate Dependent

NCT03538444Not ApplicableTerminatedPrimary

Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder

NCT03971097Not ApplicableCompleted

The Effect of Self-Forgiveness on Self-Stigma in Addiction.

NCT00634803Phase 1CompletedPrimary

Clinical Trial of Integrated Treatment for Pain and Opioid Dependence

NCT00539123Not ApplicableCompletedPrimary

Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia

NCT03235154Phase 4Completed

A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic

NCT02617628Phase 2CompletedPrimary

Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone

NCT01376570Not ApplicableCompleted

Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment

NCT01882361Phase 2CompletedPrimary

Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone

Scroll to load more

Research Network

Activity Timeline